These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7300106)

  • 1. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment.
    Lanao JM; Navarro AS; Dominguez-Gil A; Tabernero JM; Rodriguez IC; Gonzalez Lopez A
    J Antimicrob Chemother; 1983 Nov; 12(5):481-8. PubMed ID: 6671925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
    Pijck J; Hallynck T; Soep H; Baert L; Daneels R; Boelaert J
    J Infect Dis; 1976 Nov; 134 SUPPL():S331-41. PubMed ID: 993626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification in the pharmacokinetics of amikacin during development.
    Lanao JM; Dominguez-Gil A; Dominguez-Gil AA; Málaga S; Crespo M; Nuño F
    Eur J Clin Pharmacol; 1982; 23(2):155-60. PubMed ID: 7140805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum creatinine concentration and amikacin half-life.
    Levy J; Klastensky J
    J Clin Pharmacol; 1975 Oct; 15(10):705-7. PubMed ID: 1102570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of amikacin half-life during therapy in patients with renal insufficiency.
    Blaser J; Rüttimann S; Bhend H; Lüthy R
    Antimicrob Agents Chemother; 1983 Jun; 23(6):888-91. PubMed ID: 6614893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the route of administration on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Corbacho L
    Eur J Clin Pharmacol; 1981; 19(5):367-70. PubMed ID: 7238565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.
    Plantier J; Forrey AW; O'Neill MA; Blair AD; Christopher TG; Cutler RE
    J Infect Dis; 1976 Nov; 134 SUPPL():S323-30. PubMed ID: 993625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of amikacin in renal parenchyma of normal rats and of rats with acute obstructive renal insufficiency.
    Rudhardt M; Fabre J
    Nephron; 1979; 24(6):287-91. PubMed ID: 514429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of amikacin and kanamycin.
    Kirby WM; Clarke JT; Libke RD; Regamey C
    J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.